Penicillin V potassium capsule and preparation method thereof
By combining modified polylactic acid glycolic acid copolymer microspheres with fumed silica and anhydrous calcium hydrogen phosphate, the problems of poor stability and flowability of penicillin V potassium capsules in high temperature and high humidity environments were solved, achieving high drug stability and uniformity, and reducing electrostatic adhesion and powder return rate.
Patent Information
- Application Number
- CN202610669732.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-15
- Publication Date
- 2026-06-19
AI Technical Summary
Existing technologies for preparing penicillin V potassium capsules suffer from problems such as layering during mixing, drug agglomeration, electrostatic adsorption and wall adhesion, and poor flowability, resulting in poor drug stability and content, and the drug is prone to degradation, especially in high temperature and high humidity environments.
Modified polylactic acid glycolic acid copolymer microspheres are used. Through dual modification with povidone and ethyl cellulose, combined with fumed silica and anhydrous calcium hydrogen phosphate, a complex of elastic regulation and rigid framework is formed, which improves the mixing uniformity, flowability and antistatic properties of the drug, reduces water absorption, and solves the problems of electrostatic adhesion and powder return.
In high-temperature and high-humidity environments, the quality stability and mixing uniformity of penicillin V potassium capsules are significantly improved, the flowability is improved, electrostatic desorption and stratification are reduced, the return powder rate is reduced, and the drug content remains stable.